Lucid Diagnostics Inc. (LUCD) vs Neuronetics, Inc. (STIM)
Lucid Diagnostics Inc. and Neuronetics, Inc. are both Medical Devices companies. Neuronetics, Inc. is the larger, with a market value of $214.9M against $170.3M — 1.3× the size. Neuronetics, Inc. grew revenue faster over the last twelve months: 39.6% against 24.9%. Neuronetics, Inc. has the higher net margin (−19.6% vs −1,193.9%) and the higher return on invested capital (−24.6% vs −3,096.5%). Across the 17 metrics below, Neuronetics, Inc. leads on 15 and Lucid Diagnostics Inc. on 2.
Valuation
Profitability
| Metric | LUCD | STIM | Medical Devices median |
|---|---|---|---|
| Gross margin | (21.69%) | 49.12% | 56.01% |
| Operating margin | (930.84%) | (14.74%) | (15.03%) |
| Net margin | (1,193.87%) | (19.62%) | (20.40%) |
| Free cash flow margin | (866.56%) | (7.24%) | (7.24%) |
| Return on equity | 364.89% | (114.52%) | (15.32%) |
| Return on assets | (167.51%) | (22.87%) | (19.72%) |
| Return on invested capital | (3,096.53%) | (24.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack